SOURCE: Institute for Pediatric Innovation

Institute for Pediatric Innovation

July 13, 2010 14:09 ET

The Institute for Pediatric Innovation (IPI) and Children's National Medical Center Join Forces to Transform Innovative Ideas Into Products That Benefit Children's Health

Partnership Aims to Advance Best Practices in Care for the Nation's Children

CAMBRIDGE, MA--(Marketwire - July 13, 2010) -  The Institute for Pediatric Innovation has partnered with Children's National Medical Center to foster the development of medical products, including medical devices and medications, that aim to specifically address the health needs of infants and children.

"Children's National and IPI are both committed to the development of innovative products for children," said Edward M. Connor, MD, Director of the Office of Innovation and Investigational Therapeutics at Children's National. "The needs of children are often subordinate in the typical product development process, leaving pediatric health care providers to adapt adult drugs and devices to meet the needs of children. This partnership is one component of Children's National's multi-disciplinary efforts to advance new products, treatments, and practices that will change the way we care for children."

Advancing modern medical care for children requires identifying important unmet needs and providing solutions to these needs. The Institute for Pediatric Innovation has formalized a model based on a structured assessment of needs and feasibility in different pediatric settings and the facilitation of partnerships with stakeholders, including non-profit organizations, academic institutions, industry, government, foundations, and advocacy groups, for product development. 

This collaboration builds on work already underway at Children's National through the Sheikh Zayed Institute for Pediatric Surgical Innovation, the Clinical and Translational Science Institute, and Nursing Research. Children's National will participate in the IPI consortium of hospitals to share information, and will provide surgical innovation leadership to advance methods, devices, and treatments that will make pediatric surgery less-invasive, more precise, and pain-free for children. 

With this partnership, Children's National joins six additional nationally recognized children's hospitals, including Phoenix Children's Hospital, Children's Hospital of Wisconsin, The Children's Hospital of Denver, Children's Mercy Hospital and Clinics, Lucile Packard Children's Hospital, and Rainbow Babies & Children's Hospital, who share a common goal to promote innovation and the development of new products for children.

"We are very excited about Children's National as a partner with IPI," commented Donald Lombardi, CEO of IPI. "The unique challenges of product development for children require specialized expertise, and institutions like Children's National, other consortium hospitals, and IPI are making progress in facilitating pediatric product development."

About Children's National Medical Center

Children's National Medical Center, located in Washington, DC, is a proven leader in the development of innovative new treatments for childhood illness and injury. Children's has served the nation's children for more than 135 years. Children's National is ranked among the best pediatric hospitals in America by US News & World Report and the Leapfrog Group. Children's Research Institute, the academic arm of Children's National Medical Center, encompasses the translational, clinical, and community research efforts of the institution. Learn more at

About Institute for Pediatric Innovation

The Institute for Pediatric Innovation, a nonprofit 501(c)(3) organization, is improving pediatric care by stimulating development of medical devices and drugs designed specifically for treating babies and children. IPI and its consortium of six leading U.S. pediatric hospitals work with the pediatric care community to identify and design the most needed products. IPI mobilizes public, private, nonprofit and for-profit resources to achieve product development and licenses the resulting products to companies for commercial sale. IPI is led by an experienced team of experts in licensing, developing and commercializing medical devices and pharmaceutical products for pediatric medical care. To date, IPI has aggregated financing from its consortium members, the Ewing Marion Kauffman Foundation, Philips Children's Medical Ventures, Inc., AGA Medical, Oxford Bioscience Partners, University of Kansas, Cambridge Consulting and the World Health Organization (WHO). Learn more at

Contact Information

  • Institute for Pediatric Innovation contact:
    Elisabeth Mathieu
    IPI Office Manager
    Email Contact

    Press contact:
    Barbara Heffner
    Email Contact